Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
MED (Medifast Inc) has 1 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
114 institutional managers report a position in Medifast Inc worth $98.7M between them, filed on form 13F for the quarter ending 2026-06-30. 25 of them hold 80% of it, the largest being Renaissance Technologies LLC at 8.37%.
89 more managers in the register
25 managers hold 80% of the $98.7M institutional base. The other 89 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
Medifast Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Miscellaneous Food Preparations & Kindred Products
Prev close 11.98 · opened flat. High/low 12.04 at 3:00 pm ET, 11.89 at 10:15 am ET.
via Marshall Wace LLP, Peapod Lane Capital LLC, Bridgeway Capital Management Inc +4 more · 2.60% of MED, 4.66% of VRA
via Steamboat Capital Partners, LLC, Atom Investors LP, Divisadero Street Capital Management, LP · 7.60% of MED, 6.82% of PRTH
via Marshall Wace LLP, Bridgeway Capital Management Inc, Tudor Investment Corp ET AL +7 more · 2.60% of MED, 4.38% of BOOM
via Marshall Wace LLP, Peapod Lane Capital LLC, RBF Capital, LLC +3 more · 2.60% of MED, 5.65% of ARQ
via Marshall Wace LLP, Bridgeway Capital Management Inc, Trexquant Investment LP +4 more · 2.60% of MED, 2.12% of AMPY
via Marshall Wace LLP, Trexquant Investment LP, Bridgeway Capital Management Inc +2 more · 2.60% of MED, 17.44% of STEM
Managers holding a meaningful stake in MED also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.